Morgan Stanley Downgrades Mindray Medical To Underweight

Analysts at Morgan Stanley downgraded Mindray Medical International

from Equal-weight to Underweight. The price target for Mindray Medical has been lowered from $37 to $28. Mindray Medical shares have declined 24.02% over the past 52 weeks, while the S&P 500 index has gained 14.65% in the same period. Mindray Medical's shares fell 0.28% to close at $28.19 yesterday.